The Commission's final determination could lead to an import ban of Innoscience's allegedly infringing products into the U.S.The ruling is another…
$4.25 million upfront with up to an additional $4.1 million of potential aggregate gross proceeds upon the exercise in full…
MUMBAI, India, Oct. 24, 2025 /PRNewswire/ -- ProlyteORS, the flagship brand of Cipla Health Limited, welcomes the recent directive from…
October 10, 2025 17:16 ET | Source: Bluejay Diagnostics, Inc. ACTON, Mass., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics,…